Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Monday, December 12, 2011 | ENZO Biochem Reports Fiscal First Quarter 2012 Results Focus On Strategic Initiatives in Molecular Diagnostic Platforms |
Wednesday, December 07, 2011 | ENZO Biochem Schedules Teleconference to Discuss 2012 First Quarter Results on December 13, 2011 At 8:30 Am E.T. |
Friday, December 02, 2011 | 2011 Annual Report and Proxy Materials |
Wednesday, November 09, 2011 | ENZO Biochem to Present At Lazard Capital Markets 8th Annual Healthcare Conference |
Tuesday, October 18, 2011 | ENZO Reports Record Revenues of $102 Million For Fiscal Year 2011 Fourth Quarter Results Show Strong Improvement, Led By Vigorous Enzo Clinical Lab Performance |
Wednesday, October 12, 2011 | ENZO Biochem Schedules Teleconference to Discuss 2011 Fourth Quarter and Year-End Results on October 17, 2011, At 8:30 Am E.T. |
Thursday, September 08, 2011 | ENZO Biochem to Present at Rodman & Renshaw Thirteenth Annual Healthcare Conference |
Monday, August 22, 2011 | ENZO Biochem Appoints Four Executives at Enzo Life Sciences as Unit adds Products and Platforms to More Aggressively Expand in Pharmaceutical and Clinical Markets |
Wednesday, July 06, 2011 | ENZO Scientists Report On Key Discovery of Novel Targets For Metabolic Bone Disease And Other Conditions |
Tuesday, June 21, 2011 | U.S. Supreme Court Declines Life Technologies Appeal Hearing In Patent Infringement Suit Brought By ENZO Biochem Claiming Substantial Damages |
Friday, June 10, 2011 | ENZO Biochem’s Clinical Lab Acquires Marketing Rights To Unique, More Effective Diagnostic Test For Cervical Cancer |
Friday, June 10, 2011 | ENZO Biochem Reports Improved Third Quarter Results |
Thursday, June 09, 2011 | ENZO Biochem Schedules Teleconference for 3q Results |
Monday, April 04, 2011 | ENZO Biochem to Present At 10th Annual Needham Healthcare Conference |
Tuesday, March 15, 2011 | Enzo Biochem Unit Launches First-To-Market Survival Motor Neuron (SMN) Protein Immunoassay System. SMA Is Leading Geneticcause of Infant and Toddler Mortality |
Monday, March 14, 2011 | Enzo Biochem Announces Improved Fiscal 2011 Second Quarter Results |
Monday, March 14, 2011 | ENZO Biochem Schedules Teleconference to Discuss Fiscal Second Quarter Results on March 15, 2011 at 8:30 AM E.T. |
Thursday, February 24, 2011 | ENZO Biochem to Present at Citi 2011 Global Health Care Conference |